Protocol for Inpatient Nursing Frailty Assessment (INFA)
Launched by TAN TOCK SENG HOSPITAL · Jun 18, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Inpatient Nursing Frailty Assessment (INFA) trial is looking to improve the care of older adults who are frail and are admitted to the hospital. Frailty can increase the risk of serious health problems, and this study aims to better identify and address these issues early on. The INFA program involves nurses gathering important information about patients' health during their hospital stay. This information helps create a personalized care plan that connects patients with the right resources, such as specialized medical reviews and support for daily activities, to help them recover and maintain their independence.
To participate in this trial, individuals must be 65 years or older and have a mild to moderate level of frailty, as measured by a specific scale. Eligible patients will be those admitted to general medical and surgical wards, but not those coming in for planned surgeries or from nursing homes. Participants can expect to receive enhanced care tailored to their needs, which may lead to better health outcomes during and after their hospital stay. Overall, this trial is designed to make hospital care safer and more effective for frail older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria \[Pre-implementation\]:
- • 1. Participants are healthcare professionals (nurses, doctors, allied health workers, nursing/clinical leadership) who are involved in the conceptualisation, implementation and/or delivery of the INFA programme.
- • 2. They are able to share their views on the anticipated barriers and facilitators of implementing and delivering the INFA programme.
- • 3. They consent to participating in the focus group discussion or in-depth interview.
- Exclusion Criteria \[Pre-implementation\]:
- • They do not consent to participating.
- Inclusion Criteria \[Implementation\]:
- • 1. Participants are 65 years or older
- • 2. Has a Clinical Frailty Scale (CFS) rating of 4-6
- • 3. Admitted to surgical and general medical wards
- Exclusion Criteria \[Implementation\]:
- • 1. All elective admissions
- • 2. Individuals admitted from nursing or sheltered homes
- • 3. Patients who are admitted for less than 48 hours.
About Tan Tock Seng Hospital
Tan Tock Seng Hospital (TTSH) is a leading healthcare institution in Singapore, renowned for its commitment to excellence in patient care, education, and research. As a key player in the clinical research landscape, TTSH actively sponsors and conducts clinical trials across various medical specialties, aiming to advance medical knowledge and improve treatment outcomes. The hospital's robust infrastructure, multidisciplinary expertise, and strong collaborative ties with academic and research institutions enable it to facilitate innovative studies that adhere to the highest ethical and regulatory standards. Through its dedication to clinical research, TTSH strives to contribute significantly to the evolving field of medicine and enhance the health and well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, Singpaore, Singapore
Patients applied
Trial Officials
Justin Chew
Principal Investigator
Tan Tock Seng Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported